http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109394769-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c421e784c9a658a6230d092652395b70 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8b958558ea8579612b3a2ee9977712b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d3798274e38b8669e0cd7ac646a4719 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb805fe663ceadb2961c7116c22368e6 |
| publicationDate | 2019-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109394769-A |
| titleOfInvention | A kind of antithyroid cancer purposes of pyrimidine derivatives |
| abstract | The invention discloses a kind of antithyroid cancer purposes of pyrimidine derivatives.Thyroid cancer is a kind of high-incidence endocrine malignant tumour, and the cancer morbidity and Mortality data of China national cancer preventions in 2018 and control centre's publication are shown, new hair about 170,000 case of thyroid cancer of China in 2014, thyroid cancer death toll about 0.8 ten thousand.Currently, the drug of effectively treatment thyroid cancer is less, it is not able to satisfy clinical demand.Present invention discover that part pyrimidine derivatives all have significant inhibiting effect to human thyroid carcinomas B-CPAP cell, it can be used for preparing the drug for the treatment of thyroid cancer；The parent nucleus and substituent group of pyrimidine derivatives all significantly affect its drug effect to thyroid cancer. |
| priorityDate | 2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394866 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394678 |
Total number of triples: 21.